In conclusion, we preliminarily verified by in vitro experiments that ZNF8-ERVK3-1 promotes lung adenocarcinoma proliferation, migration, and invasion and that knockdown of ZNF8-ERVK3-1 leads to G0/G1 phase cycle blockage and increased apoptosis. Here, ZNF8 is linked to lung adenocarcinoma.